Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 32003 

TABLE ONE

Vessel No. 

Distance in 

meters of forward 

masthead light 

below minimum 

required height. 

§ 2(a)(i) annex I 

*******

USS DETROIT ............................................................................................................................................... LCS 7 6.80 

*******

* * * * * 

TABLE FIVE

Vessel No. 

Masthead lights 

not over all 

other lights 

and obstructions. 

annex I, sec. 2(f) 

Forward masthead 

light not in 

forward quarter 

of ship. annex I, 

sec. 3(a) 

After masthead 

light less than 1⁄2 ship’s length aft 

of forward 

masthead light. 

annex I, sec. 3(a) 

Percentage 

horizontal 

separation 

attained 

*******

USS DETROIT ............................. LCS 7 .................................. X X 23.0 

* * * * * 

Approved: May 13, 2015. 

A.B. Fischer, 

Captain, JAGC, U.S. Navy, Deputy Assistant 

Judge Advocate, General (Admiralty and 

Maritime Law). 

Dated: May 27, 2015. 

P.A. Richelmi, 

Lieutenant, Judge Advocate General’s Corps, 

U.S. Navy, Alternate Federal Register Liaison 

Officer. 

[FR Doc. 2015–13754 Filed 6–4–15; 8:45 am] 

BILLING CODE 3810–FF–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

40 CFR Parts 9 and 721 

[EPA–HQ–OPPT–2015–0220; FRL–9927–67] 

RIN 2070–AB27 

Significant New Use Rules on Certain 

Chemical Substances 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Direct final rule. 

SUMMARY: EPA is promulgating 

significant new use rules (SNURs) under 

the Toxic Substances Control Act 

(TSCA) for 22 chemical substances 

which were the subject of 

premanufacture notices (PMNs). Two of 

these chemical substances are subject to 

TSCA section 5(e) consent orders issued 

by EPA. This action requires persons 

who intend to manufacture (including 

import) or process any of these 22 

chemical substances for an activity that 

is designated as a significant new use by 

this rule to notify EPA at least 90 days 

before commencing that activity. The 

required notification will provide EPA 

with the opportunity to evaluate the 

intended use and, if necessary, to 

prohibit or limit that activity before it 

occurs. 

DATES: This rule is effective on August 

4, 2015. For purposes of judicial review, 

this rule shall be promulgated at 1 p.m. 

(e.s.t.) on June 19, 2015. 

Written adverse or critical comments, 

or notice of intent to submit adverse or 

critical comments, on one or more of 

these SNURs must be received on or 

before July 6, 2015 (see Unit VI. of the 

SUPPLEMENTARY INFORMATION). If EPA 

receives written adverse or critical 

comments, or notice of intent to submit 

adverse or critical comments, on one or 

more of these SNURs before July 6, 

2015, EPA will withdraw the relevant 

sections of this direct final rule before 

its effective date. 

For additional information on related 

reporting requirement dates, see Units 

I.A., VI., and VII. of the SUPPLEMENTARY

INFORMATION. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2015–0220, by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Do not submit electronically any 

information you consider to be 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. 

• Mail: Document Control Office 

(7407M), Office of Pollution Prevention 

and Toxics (OPPT), Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW., Washington, DC 20460–0001. 

• Hand Delivery: To make special 

arrangements for hand delivery or 

delivery of boxed information, please 

follow the instructions at http://

www.epa.gov/dockets/contacts.html. 

Additional instructions on 

commenting or visiting the docket, 

along with more information about 

dockets generally, is available at 

http://www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT:

For technical information contact: 

Kenneth Moss, Chemical Control 

Division (7405M), Office of Pollution 

Prevention and Toxics, Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW., Washington, DC 20460–0001; 

telephone number: (202) 564–9232; 

email address: moss.kenneth@epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

mstockstill on DSK4VPTVN1PROD with RULES

32004 Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you manufacture, process, 

or use the chemical substances 

contained in this rule. The following list 

of North American Industrial 

Classification System (NAICS) codes is 

not intended to be exhaustive, but rather 

provides a guide to help readers 

determine whether this document 

applies to them. Potentially affected 

entities may include: 

• Manufacturers or processors of one 

or more subject chemical substances 

(NAICS codes 325 and 324110), e.g., 

chemical manufacturing and petroleum 

refineries. 

This action may also affect certain 

entities through pre-existing import 

certification and export notification 

rules under TSCA. Chemical importers 

are subject to the TSCA section 13 (15 

U.S.C. 2612) import certification 

requirements promulgated at 19 CFR 

12.118 through 12.127 and 19 CFR 

127.28. Chemical importers must certify 

that the shipment of the chemical 

substance complies with all applicable 

rules and orders under TSCA. Importers 

of chemicals subject to these SNURs 

must certify their compliance with the 

SNUR requirements. The EPA policy in 

support of import certification appears 

at 40 CFR part 707, subpart B. In 

addition, any persons who export or 

intend to export a chemical substance 

that is the subject of a proposed or final 

rule are subject to the export 

notification provisions of TSCA section 

12(b) (15 U.S.C. 2611(b)) (see § 721.20), 

and must comply with the export 

notification requirements in 40 CFR part 

707, subpart D. 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not submit this 

information to EPA through 

regulations.gov or email. Clearly mark 

the part or all of the information that 

you claim to be CBI. For CBI 

information in a disk or CD–ROM that 

you mail to EPA, mark the outside of the 

disk or CD–ROM as CBI and then 

identify electronically within the disk or 

CD–ROM the specific information that 

is claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

accordance with procedures set forth in 

40 CFR part 2. 

2. Tips for preparing your comments. 

When preparing and submitting your 

comments, see the commenting tips at 

http://www.epa.gov/dockets/

comments.html. 

II. Background 

A. What action is the Agency taking? 

EPA is promulgating these SNURs 

using direct final procedures. These 

SNURs will require persons to notify 

EPA at least 90 days before commencing 

the manufacture or processing of a 

chemical substance for any activity 

designated by these SNURs as a 

significant new use. Receipt of such 

notices allows EPA to assess risks that 

may be presented by the intended uses 

and, if appropriate, to regulate the 

proposed use before it occurs. 

Additional rationale and background to 

these rules are more fully set out in the 

preamble to EPA’s first direct final 

SNUR published in the Federal Register 

issue of April 24, 1990 (55 FR 17376) 

(FRL–3658–5). Consult that preamble 

for further information on the 

objectives, rationale, and procedures for 

SNURs and on the basis for significant 

new use designations, including 

provisions for developing test data. 

B. What is the Agency’s authority for 

taking this action? 

Section 5(a)(2) of TSCA (15 U.S.C. 

2604(a)(2)) authorizes EPA to determine 

that a use of a chemical substance is a 

‘‘significant new use.’’ EPA must make 

this determination by rule after 

considering all relevant factors, 

including the four bulleted TSCA 

section 5(a)(2) factors listed in Unit III. 

Once EPA determines that a use of a 

chemical substance is a significant new 

use, TSCA section 5(a)(1)(B) requires 

persons to submit a significant new use 

notice (SNUN) to EPA at least 90 days 

before they manufacture or process the 

chemical substance for that use. Persons 

who must report are described in 

§ 721.5. 

C. Applicability of General Provisions 

General provisions for SNURs appear 

in 40 CFR part 721, subpart A. These 

provisions describe persons subject to 

the rule, recordkeeping requirements, 

exemptions to reporting requirements, 

and applicability of the rule to uses 

occurring before the effective date of the 

rule. Provisions relating to user fees 

appear at 40 CFR part 700. According to 

§ 721.1(c), persons subject to these 

SNURs must comply with the same 

SNUN requirements and EPA regulatory 

procedures as submitters of PMNs under 

TSCA section 5(a)(1)(A). In particular, 

these requirements include the 

information submission requirements of 

TSCA section 5(b) and 5(d)(1), the 

exemptions authorized by TSCA section 

5(h)(1), (h)(2), (h)(3), and (h)(5), and the 

regulations at 40 CFR part 720. Once 

EPA receives a SNUN, EPA may take 

regulatory action under TSCA section 

5(e), 5(f), 6, or 7 to control the activities 

for which it has received the SNUN. If 

EPA does not take action, EPA is 

required under TSCA section 5(g) to 

explain in the Federal Register its 

reasons for not taking action. 

III. Significant New Use Determination 

Section 5(a)(2) of TSCA states that 

EPA’s determination that a use of a 

chemical substance is a significant new 

use must be made after consideration of 

all relevant factors, including: 

• The projected volume of 

manufacturing and processing of a 

chemical substance. 

• The extent to which a use changes 

the type or form of exposure of human 

beings or the environment to a chemical 

substance. 

• The extent to which a use increases 

the magnitude and duration of exposure 

of human beings or the environment to 

a chemical substance. 

• The reasonably anticipated manner 

and methods of manufacturing, 

processing, distribution in commerce, 

and disposal of a chemical substance. 

In addition to these factors 

enumerated in TSCA section 5(a)(2), the 

statute authorized EPA to consider any 

other relevant factors. 

To determine what would constitute a 

significant new use for the 22 chemical 

substances that are the subject of these 

SNURs, EPA considered relevant 

information about the toxicity of the 

chemical substances, likely human 

exposures and environmental releases 

associated with possible uses, and the 

four bulleted TSCA section 5(a)(2) 

factors listed in this unit. 

IV. Substances Subject to This Rule 

EPA is establishing significant new 

use and recordkeeping requirements for 

22 chemical substances in 40 CFR part 

721, subpart E. In this unit, EPA 

provides the following information for 

each chemical substance: 

• PMN number. 

• Chemical name (generic name, if 

the specific name is claimed as CBI). 

• Chemical Abstracts Service (CAS) 

Registry number (assigned for nonconfidential chemical identities). 

• Basis for the TSCA section 5(e) 

consent order or, the basis for the TSCA 

non-section 5(e) SNURs (i.e., SNURs 

without TSCA section 5(e) consent 

orders). 

• Tests recommended by EPA to 

provide sufficient information to 

mstockstill on DSK4VPTVN1PROD with RULES

Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 32005 

evaluate the chemical substance (see 

Unit VIII. for more information). 

• CFR citation assigned in the 

regulatory text section of this rule. 

The regulatory text section of this rule 

specifies the activities designated as 

significant new uses. Certain new uses, 

including production volume limits 

(i.e., limits on manufacture volume) and 

other uses designated in this rule, may 

be claimed as CBI. Unit IX. discusses a 

procedure companies may use to 

ascertain whether a proposed use 

constitutes a significant new use. 

This rule includes 2 PMN substances 

(P–13–930 and P–14–763) that are 

subject to ‘‘risk-based’’ consent orders 

under TSCA section 5(e)(1)(A)(ii)(I) 

where EPA determined that activities 

associated with the PMN substances 

may present unreasonable risk to human 

health or the environment. Those 

consent orders require protective 

measures to limit exposures or 

otherwise mitigate the potential 

unreasonable risk. The so-called ‘‘TSCA 

section 5(e) SNURs’’ on these PMN 

substances are promulgated pursuant to 

§ 721.160, and are based on and 

consistent with the provisions in the 

underlying consent orders. The TSCA 

section 5(e) SNURs designate as a 

‘‘significant new use’’ the absence of the 

protective measures required in the 

corresponding consent orders. 

This rule also includes SNURs on 20 

PMN substances that are not subject to 

consent orders under TSCA section 5(e). 

In these cases, for a variety of reasons, 

EPA did not find that the use scenario 

described in the PMN triggered the 

determinations set forth under TSCA 

section 5(e). However, EPA does believe 

that certain changes from the use 

scenario described in the PMN could 

result in increased exposures, thereby 

constituting a ‘‘significant new use.’’ 

These so-called ‘‘TSCA non-section 5(e) 

SNURs’’ are promulgated pursuant to 

§ 721.170. EPA has determined that 

every activity designated as a 

‘‘significant new use’’ in all TSCA nonsection 5(e) SNURs issued under 

§ 721.170 satisfies the two requirements 

stipulated in § 721.170(c)(2), i.e., these 

significant new use activities are 

different from those described in the 

premanufacture notice for the 

substance, including any amendments, 

deletions, and additions of activities to 

the premanufacture notice, and may be 

accompanied by changes in exposure or 

release levels that are significant in 

relation to the health or environmental 

concerns identified’’ for the PMN 

substance. 

PMN Number P–11–549 

Chemical name: 2-Butene, 1,1,1,4,4,4- 

hexafluoro-, (2Z)-. 

CAS number: 692–49–9. 

Basis for action: The PMN states that 

the generic (non-confidential) use of the 

substance will be as a heat transfer 

fluid. Based on test data on the PMN 

substance as well as structure activity 

relationship (SAR) analysis of analogous 

small fluorinated compounds, EPA 

identified concerns for cardiac 

sensitization, developmental toxicity, 

neurotoxicity, reproductive toxicity and 

oncogenicity from inhalation exposures 

to the PMN substance. As described in 

the PMN, occupational exposures are 

expected to be minimal due to no 

domestic manufacture and consumer 

exposure is not expected due to no use 

of the substance in a consumer product. 

Therefore, EPA has not determined that 

the proposed processing or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any domestic manufacture, any use 

other than as described in the PMN, or 

any use of the substance in a consumer 

product may cause serious health 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(3)(i) and 

(b)(3)(ii). 

Recommended testing: EPA has 

determined that inhalation monitoring 

data, collected according to the EPA 

draft Inhalation Monitoring Data 

Collection Guidelines (located in the 

docket under docket ID number EPA– 

HQ–OPPT–2015–0220) would help 

characterize the human health effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10830. 

PMN Number P–13–690 

Chemical name: Aluminum 

phosphate (generic). 

CAS number: Claimed confidential. 

Basis for action: The PMN states that 

the substance will be used as a flame 

retardant for industrial plastics. Based 

on SAR analysis of test data on 

analogous respirable, poorly soluble 

particulates, EPA identified concerns for 

lung effects, blood toxicity, 

hypersensitivity, developmental 

neurotoxicity, and immunotoxicity from 

inhalation exposures to the PMN 

substance. Further, based on ecological 

SAR analysis of test data on analogous 

aluminum salts, EPA predicts toxicity to 

aquatic organisms may occur at 

concentrations that exceed 87 parts per 

billion (ppb) of the PMN substance in 

surface waters. As described in the 

PMN, occupational exposures are 

expected to be minimal due to use of 

respiratory protection, and releases of 

the substance are not expected to result 

in surface water concentrations that 

exceed 87 ppb. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any use of the PMN substance without 

the use of National Institute of 

Occupational Safety and Health 

(NIOSH)-certified respirator with an 

assigned protection factor (APF) of at 

least 10, where inhalation exposures are 

expected, or any use of the substance 

resulting in surface water 

concentrations exceeding 87 ppb may 

cause serious human health effects and 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at 40 CFR 721.170(b)(3)(ii) and 

(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a 90-day 

inhalation toxicity test (OPPTS Test 

Guideline 870.3465 or Organisation for 

Economic Co-operation and 

Development (OECD) Test Guideline 

413); a fish early-life stage toxicity test 

(OPPTS Test Guideline 850.1400); a 

daphnid chronic toxicity test (OPPTS 

Test Guideline 850.1300); and an algal 

toxicity test (Office of Chemical Safety 

and Pollution Prevention (OCSPP) Test 

Guideline 850.4500) would help 

characterize the human health and 

environmental effects of the PMN 

substance. EPA also recommends that 

the guidance document on aquatic 

toxicity testing of difficult substance 

and mixtures (OECD Test Guideline 23) 

be consulted to facilitate solubility of 

the PMN substance in the test media. 

CFR citation: 40 CFR 721.10831. 

PMN Number P–13–872 

Chemical name: Alkyl triazine 

(generic). 

CAS number: Claimed confidential. 

Basis for action: The PMN states that 

the substance will be used in the 

removal of hydrogen sulfide. Based on 

test data on the PMN substance, as well 

as ecological SAR analysis of test data 

on analogous aliphatic amines, EPA 

predicts toxicity to aquatic organisms 

may occur at concentrations that exceed 

130 ppb of the PMN substance in 

surface waters. As described in the 

PMN, releases of the substance are not 

expected to result in surface water 

concentrations that exceed 130 ppb. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that any use of 

the substance resulting in surface water 

concentrations exceeding 130 ppb may 

mstockstill on DSK4VPTVN1PROD with RULES

32006 Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 

cause significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(i) and 

(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a fish 

early-life stage toxicity test (OPPTS Test 

Guideline 850.1400) and a daphnid 

chronic toxicity test (OPPTS Test 

Guideline 850.1300) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10832. 

PMN Number P–13–930 

Chemical name: Substituted bis 2,6- 

xylenol (generic). 

CAS number: Claimed confidential. 

Effective date of TSCA section 5(e) 

consent order: December 10, 2014. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the generic 

(non-confidential) use of the substance 

will be as a reactant in polymerization 

reactions. Based on SAR analysis of test 

data on structurally similar substances, 

EPA identified concerns for liver, 

kidney and developmental toxicity; 

blood effects, sensitization, and 

endocrine disruption. Further, based on 

test data on the PMN substance, EPA 

predicts toxicity to aquatic organisms at 

concentrations that exceed 6 ppb of the 

PMN substance in surface waters. The 

order was issued under TSCA sections 

5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(I), based 

on a finding that the substance may 

present an unreasonable risk of injury to 

the environment and human health, and 

there may be significant (or substantial) 

human exposure to the substance. To 

protect against these exposures and 

risks, the consent order requires: 

1. Use of personal protective 

equipment involving impervious gloves 

and protective clothing (where there is 

a potential for dermal exposure) and a 

NIOSH-certified respirator with an APF 

of at least 50 (where there is a potential 

for inhalation exposure). 

2. Establishment and use of a hazard 

communication program, including 

human health, environmental hazard 

precautionary statements on each label 

and the MSDS. 

3. Manufacturing, processing, or use 

of the PMN substance only as an 

intermediate. 

4. Submission of certain toxicity 

testing prior to exceeding the 

confidential production volume limits 

of the PMN substance specified in the 

consent order. 

5. No predictable or purposeful 

release of the PMN substance from 

manufacturing, processing or use into 

the waters of the United States that 

result in surface water concentrations 

exceeding 6 ppb. 

The SNUR designates as a ‘‘significant 

new use’’ the absence of these protective 

measures. 

Recommended testing: EPA has 

determined that the results of certain 

toxicity testing, identified in the TSCA 

5(e) consent order would help 

characterize possible effects of the 

substance. The submitter has agreed not 

to exceed the first confidential volume 

limit without performing an aromatase 

(human recombinant) test (OCSPP Test 

Guideline 890.1200) and a 

steroidogenesis (human cell line-H295R) 

test (OCSPP Test Guideline 890.1550 or 

OECD Test Guideline 456). Further, the 

Order prohibits the Company from 

exceeding the second confidential 

production volume limit unless the 

Company submits the Tier 2 testing 

described in the Testing section of this 

Order in accordance with the conditions 

specified in the Testing section. 

CFR citation: 40 CFR 721.10833. 

PMN Number P–14–20 

Chemical name: Heteropolycyclic 

diacrylate (generic). 

CAS number: Claimed confidential. 

Basis for action: The PMN states that 

the generic (non-confidential) use of the 

substance will be as a coating resin. 

Based on test data on the PMN, EPA 

identified concerns for dermal and 

ocular irritation, and systemic toxicity 

from the dermal, ocular, and oral routes. 

Further, based on ecological SAR 

analysis of test data on analogous 

acrylates, EPA predicts toxicity to 

aquatic organisms may occur at 

concentrations that exceed 120 ppb of 

the PMN substance in surface waters. As 

described in the PMN, occupational 

exposures are expected to be minimal 

due to the use of impervious gloves, 

goggles, and a NIOSH-certified 

particulate respirator with an APF of at 

least 10. Further, releases of the 

substance are not expected to result in 

surface water concentrations that exceed 

120 ppb. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any use of the substance without the use 

of impervious gloves and goggles, when 

there is a potential dermal exposure; 

any use of the substance without a 

NIOSH-certified particulate respirator 

with an APF of at least 10, where there 

is a potential for inhalation exposures; 

or any use of the substance resulting in 

surface water concentrations exceeding 

120 ppb may cause serious health 

effects and significant adverse 

environmental effects. Based on this 

information, the PMN substance meets 

the concern criteria at § 721.170(b)(3)(i) 

and (b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a 

combined repeated dose toxicity with 

the reproduction/developmental 

toxicity screening test (OPPTS Test 

Guideline 870.3650); a fish early-life 

stage toxicity test (OPPTS Test 

Guideline 850.1400); a daphnid chronic 

toxicity test (OPPTS Test Guideline 

850.1300); and an algal toxicity test 

(OCSPP Test Guideline 850.4500) would 

help characterize the human health and 

environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10834. 

PMN Number P–14–66 

Chemical name: 1,6-Hexanediamine, 

N1-(6-aminohexyl)-, polymer with 2- 

(chloromethyl)oxirane, N- 

(dithiocarboxy) derivs., sodium salts. 

CAS number: 1459738–70–5. 

Basis for action: The PMN states that 

the substance will be used as a water 

clarifier intermediate. Based on 

ecological SAR analysis of test data on 

analogous dithiocarbamates, EPA 

predicts toxicity to aquatic organisms 

may occur at concentrations that exceed 

1 ppb of the PMN substance in surface 

waters. As described in the PMN, 

releases of the substance are not 

expected to result in surface water 

concentrations that exceed 1 ppb. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that any use of 

the substance that results in surface 

water concentrations exceeding 1 ppb 

may cause significant adverse 

environmental effects. Based on this 

information, the PMN substance meets 

the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a mysid 

acute toxicity test (OCSPP Test 

Guideline 850.1035); a fish acute 

toxicity test, freshwater and marine 

(OPPTS Test Guideline 850.1075); an 

acute invertebrate toxicity test, 

freshwater daphnids (OPPTS Test 

Guideline 850.1010); and an algal 

toxicity test (OCSPP Test Guideline 

850.4500) would help characterize the 

environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10835. 

PMN Number P–14–209 

Chemical name: Dimethylaminoalkyl 

alkene amide (generic). 

CAS number: Claimed confidential. 

mstockstill on DSK4VPTVN1PROD with RULES

Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 32007 

Basis for action: The PMN states that 

the generic (non-confidential) use of the 

substance will be as an adjuvant for 

non-Federal Insecticide, Fungicide, and 

Rodenticide Act (FIFRA)-regulated 

agricultural use products, an additive 

for pesticide formulations, and an 

additive for fertilizer formulations. 

Based on test data on the PMN 

substance, as well as ecological SAR 

analysis of test data on analogous 

amides and aliphatic amines, EPA 

predicts chronic toxicity to aquatic 

organisms may occur at concentrations 

that exceed 4 ppb of the PMN substance 

in surface waters for greater than 20 

days per year. This 20-day criterion is 

derived from partial life cycle tests 

(daphnid chronic and fish early-life 

stage tests) that typically range from 21 

to 28 days in duration. EPA predicts 

toxicity to aquatic organisms may occur 

if releases of the PMN substance to 

surface water exceed releases from the 

use described in the PMN. For the uses 

described in the PMN, environmental 

releases did not exceed the 

concentration of concern for more than 

20 days per year. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

use of the substance other than as 

described in the PMN may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substances meet the concern 

criteria at § 721.170(b)(4)(i) and 

(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a fish 

early-life stage toxicity test (OPPTS Test 

Guideline 850.1400) and a daphnid 

chronic toxicity test (OPPTS Test 

Guideline 850.1300) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10836. 

PMN Number P–14–452 

Chemical name: Substituted 

naphthalene polymer glycidyl ether 

(generic). 

CAS number: Claimed confidential. 

Basis for action: The PMN states that 

the generic (non-confidential) uses of 

the substance will be as a matrix resin 

for composite materials and a binder 

resin for electronic materials. Based on 

ecological SAR analysis of test data on 

analogous polyepoxides, EPA predicts 

toxicity to aquatic organisms may occur 

at concentrations that exceed 1 ppb of 

the PMN substance in surface waters. As 

described in the PMN, releases of the 

substance are not expected to result in 

surface water concentrations that exceed 

1 ppb. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any use of the substance resulting in 

surface water concentrations exceeding 

1 ppb may cause significant adverse 

environmental effects. Based on this 

information, the PMN substance meets 

the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a fish 

early-life stage toxicity test (OPPTS Test 

Guideline 850.1400); a daphnid chronic 

toxicity test (OPPTS Test Guideline 

850.1300); and an algal toxicity test 

(OCSPP Test Guideline 850.4500) would 

help characterize the environmental 

effects of the PMN substance. 

CFR citation: 40 CFR 721.10837. 

PMN Number P–14–473 

Chemical name: Alkylpolycarboxylic 

acid, derivative, 

tris(fluorinatedalkoxy)alkyl ester salt 

(generic). 

CAS number: Claimed confidential. 

Basis for action: The PMN states that 

the generic (non-confidential) use of the 

substance will be for coatings and 

printing applications. Based on 

ecological SAR analysis of test data on 

analogous anionic surfactants, EPA 

predicts toxicity to aquatic organisms 

may occur at concentrations that exceed 

6 ppb of the PMN substance in surface 

waters. As described in the PMN, 

releases of the substance are not 

expected to result in surface water 

concentrations that exceed 6 ppb. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that any use of 

the substance resulting in surface water 

concentrations exceeding 6 ppb may 

cause significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a water 

solubility study (OECD Test Guideline 

105); a fish acute toxicity test, 

freshwater and marine (OPPTS Test 

Guideline 850.1075); a fish early-life 

stage toxicity test (OPPTS Test 

Guideline 850.1400); and a daphnid 

chronic toxicity test (OPPTS Test 

Guideline 850.1300) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10838. 

PMN Number P–14–476 

Chemical name: 

Tricyclo[3.3.1.13,7]decan-1-amine, N,Ndimethyl-. 

CAS number: 3717–40–6. 

Basis for action: The PMN states that 

the generic (non-confidential) use of the 

substance will be as an isolated 

intermediate. Based on ecological SAR 

analysis of test data on analogous 

aliphatic amines, EPA predicts toxicity 

to aquatic organisms may occur at 

concentrations that exceed 8 ppb of the 

PMN substance in surface waters. As 

described in the PMN, releases of the 

substance are not expected to result in 

surface water concentrations that exceed 

8 ppb. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined that any use 

of the substance resulting in surface 

water concentrations exceeding 8 ppb 

may cause significant adverse 

environmental effects. Based on this 

information, the PMN substance meets 

the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a fish 

early-life stage toxicity test (OPPTS Test 

Guideline 850.1400); a daphnid chronic 

toxicity test (OPPTS Test Guideline 

850.1300); and an algal toxicity test 

(OCSPP Test Guideline 850.4500) would 

help characterize the environmental 

effects of the PMN substance. 

CFR citation: 40 CFR 721.10839. 

PMN Number P–14–510 

Chemical name: Sulfosuccinic acid 

ester, alkylamine derivs., sodium salt 

(generic). 

CAS number: Claimed confidential. 

Basis for action: The PMN states that 

the generic (non-confidential) use of the 

substance will be as an industrial 

leather softener. Based on test data on 

the PMN substance as well as SAR 

analysis of test data on analogous 

anionic surfactants, EPA predicts 

toxicity to aquatic organisms may occur 

at concentrations that exceed 94 ppb of 

the PMN substance in surface waters. As 

described in the PMN, releases of the 

substance are not expected to result in 

surface water concentrations that exceed 

94 ppb. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any use of the substance resulting in 

surface water concentrations exceeding 

94 ppb may cause significant adverse 

environmental effects. Based on this 

information, the PMN substance meets 

mstockstill on DSK4VPTVN1PROD with RULES

32008 Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 

the concern criteria at § 721.170(b)(4)(i) 

and (b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a fish 

early-life stage toxicity test (OPPTS Test 

Guideline 850.1400) and a daphnid 

chronic toxicity test (OPPTS Test 

Guideline 850.1300) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10840. 

PMN Number P–14–603 

Chemical name: Bismuth nitrate 

oxide (Bi3(NO3)O4). 

CAS number: 1417164–49–8. 

Basis for action: The PMN states that 

the generic (non-confidential) use of the 

substance will be as a proprietary 

degradation inhibitor additive in 

polymer-based insulation sheets. Based 

on test data on analogous respirable, 

poorly soluble particulates, EPA 

identified concerns for lung effects from 

inhalation exposures to the PMN 

substance. For the use described in the 

PMN, significant inhalation exposures 

are not expected. Therefore, EPA has 

not determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any use of the substance other than as 

listed in the PMN, or without 

respiratory protection, may cause 

serious health effects. Based on this 

information, the PMN substance meets 

the concern criteria at 

§ 721.170(b)(3)(ii). 

Recommended testing: EPA has 

determined that the results of a 90-day 

inhalation toxicity study with a 60-day 

holding period (OPPTS Test Guideline 

870.3465) would help characterize the 

human health effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10841. 

PMN Number P–14–605 

Chemical name: Substituted 

cyclosiloxane (generic). 

CAS number: Claimed confidential. 

Basis for action: The PMN states that 

the use of the substance will be as a 

refractive index modifier component for 

light-emitting diode (LED) chips. Based 

on the physical/chemical properties of 

the PMN substance (as described in the 

New Chemical Program’s PBT category 

at 64 FR 60194; November 4, 1999) and 

test data on structurally similar 

substances, the PMN substance is a 

potentially persistent, bioaccumulative, 

and toxic (PBT) chemical. EPA 

estimates that the PMN substance will 

persist in the environment more than 2 

months and estimates a 

bioaccumulation factor of greater than 

or equal to 1,000. As described in the 

PMN notice, the PMN substance will 

not be released to water. Therefore, EPA 

has not determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any use of the substance other than as 

described in the PMN or resulting in 

releases to water may cause serious 

health effects and significant adverse 

environmental effects. Based on this 

information, the PMN substance meets 

the concern criteria at 

§ 721.170(b)(3)(ii), (b)(4)(ii), and 

(b)(4)(iii). 

Recommended testing: EPA has 

determined that the results of a partition 

coefficient (n-octanol/water) test, 

estimation by liquid chromatography 

(OPPTS Test Guideline 830.7570 or 

OECD Test Guideline 117); a ready 

biodegradability test (OPPTS Test 

Guideline 835.3110 or OECD Test 

Guideline 301); a fish bioconcentration 

factor (BCF) test (OPPTS Test Guideline 

850.1730 or (OECD Test Guideline 305); 

and a water solubility test (OECD Test 

Guideline 111) would help characterize 

the health and environmental effects of 

the PMN substance. Depending on the 

results of these tests, additional testing 

as identified in the PBT category may be 

recommended. 

CFR citation: 40 CFR 721.10842. 

PMN Numbers P–14–666 and P–14–668 

Chemical names: Substituted amide 

aromatic carboxylic acid, metal salt 

(generic). 

CAS numbers: Claimed confidential. 

Basis for action: The PMNs state that 

the generic (non-confidential) use of the 

substances will be as morphology 

modifiers for plastics. Based on 

ecological SAR analysis of test data on 

analogous amides, EPA predicts toxicity 

to aquatic organisms may occur at 

concentrations that exceed 67 ppb of the 

PMN substance (P–14–666) and 39 ppb 

of the PMN substance (P–14–668) in 

surface waters for greater than 20 days 

per year. This 20-day criterion is 

derived from partial life cycle tests 

(daphnid chronic and fish early-life 

stage tests) that typically range from 21 

to 28 days in duration. EPA predicts 

toxicity to aquatic organisms may occur 

if releases of the substances to surface 

water, from uses other than as described 

in the PMNs, exceed releases from the 

uses described in the PMNs. For the use 

described in the PMNs, environmental 

releases did not exceed 67 ppb (P–14– 

666) and 39 ppb (P–14–668) for more 

than 20 days per year. Therefore, EPA 

has not determined that the proposed 

manufacturing, processing, or use of the 

substances may present an unreasonable 

risk. EPA has determined, however, that 

any use of the substances other than as 

listed in the PMNs may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substances meet the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a ready 

biodegradability test (OPPTS Test 

Guideline 835.3110); a fish early-life 

stage toxicity test (OPPTS Test 

Guideline 850.1400); a daphnid chronic 

toxicity test (OPPTS Test Guideline 

850.1300); and an algal toxicity test 

(OCSPP Test Guideline 850.4500) on 

each PMN substance would help 

characterize their environmental effects. 

CFR citation: 40 CFR 721.10843. 

PMN Number P–14–763 

Chemical name: Graphene 

nanoplatelets having a predominant 

thickness of 1–10 layers with lateral 

dimension predominantly less than 2 

microns. 

CAS number: Not Available 

Effective date of TSCA section 5(e) 

consent order: December 30, 2014. 

Basis for TSCA section 5(e) consent 

order: The PMN states that the generic 

(non-confidential) use of the substance 

will be in printed electronics, solar 

energy, separations, and functional 

composites. Based on SAR analysis of 

test data on respirable, poorly soluble 

particulates and analogous carbon 

nanomaterials, EPA identified concerns 

for pulmonary toxicity, oncogenicity, 

immunotoxicity, fibrosis, and lung 

toxicity from lung overload. The order 

was issued under TSCA sections 

5(e)(1)(A)(i) and 5(e)(1)(A)(ii)(I), based 

on a finding that these substance may 

present an unreasonable risk of injury to 

the environment and human health, and 

there may be significant (or substantial) 

human exposure to the substance. To 

protect against these exposures and 

risks, the consent order requires: 

1. Use of personal protective 

equipment involving impervious gloves 

and protective clothing (where there is 

a potential for dermal exposure) and a 

NIOSH-certified respirator (where there 

is a potential for inhalation exposure). 

2. Establishment and use of a hazard 

communication program, including 

human health, environmental hazard 

precautionary statements on each label 

and the MSDS. 

3. Manufacturing, processing, or use 

of the PMN substance only as described 

in the consent order. 

4. No use of the PMN substance using 

an application method that generates a 

vapor, mist, or aerosol. 

5. Submission of certain toxicity 

testing prior to exceeding the 

confidential production volume limits 

mstockstill on DSK4VPTVN1PROD with RULES

Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 32009 

of the PMN substances specified in the 

consent order. 

6. No predictable or purposeful 

release of the PMN substances from 

manufacturing, processing or use into 

the waters of the United States. 

The SNUR designates as a ‘‘significant 

new use’’ the absence of these protective 

measures. 

Recommended testing: EPA has 

determined that the results of certain 

particle size distribution and material 

characterization testing would be 

needed for the PMN substance. The 

company has agreed to submit the full 

chemical characterization testing 

described in the testing section of the 

consent order within the timeframes 

identified in the order. Further, 

depending on the results of the 

characterization testing, additional 

toxicity testing may be required at a 

confidential aggregate manufacture 

volume, as detailed in the consent 

order. 

CFR citation: 40 CFR 721.10844. 

PMN Number P–14–781 

Chemical name: Methanaminium, N- 

[4-[[4-(dimethylamino)phenyl]

phenylmethylene]-2,5-cyclohexadien-1- 

ylidene]-N-methyl-, ethanedioate, 

ethanedioate (2:2:1). 

CAS number: 2437–29–8. 

Basis for action: The PMN states that 

the generic (non-confidential) use of the 

substance will be as a component of 

industrial inks and dyes. Based on test 

data on analogous malachite green 

chloride, pararosaniline, gentian violet, 

crystal violet, oxalic acid, and other 

analogous substances, EPA identified 

concerns for mutagenicity, 

carcinogenicity, eye irritation, as well as 

kidney, acute, and developmental 

toxicities for occupational inhalation 

exposures and general population 

exposures from drinking water 

exposures. In addition, based on 

ecological SAR analysis of test data on 

analogous cationic dyes, EPA predicts 

toxicity to aquatic organisms may occur 

at concentrations that exceed 1 ppb of 

the PMN substance in surface waters. As 

described in the PMN, occupational 

exposures during processing and use 

activities are expected to be minimal. 

Further, releases of the PMN substance 

are not expected to result in surface 

water concentrations that exceed 1 ppb. 

Therefore, EPA has not determined that 

the proposed processing or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any domestic manufacture of the 

substance, or any release of the 

substance resulting in surface water 

concentrations exceeding 1 ppb may 

cause serious health effects and 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(3)(ii) and 

(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a 

combined repeated dose toxicity with 

the reproduction/developmental 

toxicity screening test (OECD Test 

Guideline 422); a bacterial reverse 

mutation test (OECD Test Guideline 

471); an in vitro mammalian 

chromosome aberration test (OECD Test 

Guideline 473); a fish acute toxicity test, 

freshwater and marine (OPPTS Test 

Guideline 850.1075); an aquatic 

invertebrate acute toxicity test (OPPTS 

Test Guideline 850.1010); and an algal 

toxicity test (OCSPP Test Guideline 

850.4500) would help characterize the 

human health an environmental effects 

of the PMN substance. 

CFR citation: 40 CFR 721.10845. 

PMN Number P–14–811 

Chemical name: Sulfurized 

hydrocarbon (generic). 

CAS number: Claimed confidential. 

Basis for action: The PMN states that 

the use of the substance will be as a 

lubricant additive. Based on ecological 

SAR analysis of test data on analogous 

neutral organics, EPA predicts toxicity 

to aquatic organisms may occur at 

concentrations that exceed 1 ppb of the 

low molecular weight components of 

PMN substance in surface waters. As 

described in the PMN, where 80 percent 

of the molecular weight species is 

greater than 1,000 daltons, releases of 

the substance are not expected to result 

in surface water concentrations that 

exceed 1 ppb of the low molecular 

weight components. Therefore, EPA has 

not determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any use of the substance where less than 

80 percent of the molecular weight 

species is greater than 1,000 daltons, 

may cause significant adverse 

environmental effects. Based on this 

information, the PMN substance meets 

the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of an 

inherent biodegradability Zahn-Wellens 

test (OECD Test Guideline 302); an 

aerobic and anaerobic transformation in 

soil test (OECD Test Guideline 307); a 

fish BCF test: Aqueous and dietary 

exposure (OECD Test Guideline 305); a 

bioaccumulation in sediment-dwelling 

benthic oligochaetes test (OECD Test 

Guideline 315); a sediment-water 

chironomid toxicity test using spiked 

sediment (OECD Test Guideline 218); a 

fish early-life stage toxicity test (OPPTS 

Test Guideline 850.1400); a daphnid 

chronic toxicity test (OPPTS Test 

Guideline 850.1300); and an algal 

toxicity test (OCSPP Test Guideline 

850.4500) would help characterize the 

environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10846. 

PMN Number P–14–821 

Chemical name: 

Oxiranemethanaminium, N,N,Ntrimethyl-, bromide. 

CAS number: 13895–77–7. 

Basis for action: The PMN states that 

the substance will be used as an 

intermediate for polymer production. 

Based on test data on analogous 

epoxides, EPA identified concerns for 

skin and lung sensitization, 

mutagenicity, oncogenicity, 

developmental toxicity, male 

reproductive, liver, and kidney toxicity 

from dermal and inhalation exposures. 

Further, based on ecological SAR 

analysis of test data on analogous 

quaternary ammonium compounds, 

EPA predicts toxicity to aquatic 

organisms may occur at concentrations 

that exceed 28 ppb of the PMN 

substance in surface waters. As 

described in the PMN, particulate 

exposures are not expected and releases 

of the substance are not expected to 

result in surface water concentrations 

that exceed 28 ppb. Therefore, EPA has 

not determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any manufacture, processing, or use of 

the substance in the form of a powder 

or any use of the substance resulting in 

surface water concentrations exceeding 

28 ppb may cause serious health effects 

and significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(3)(ii) and 

(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a 90-day 

inhalation toxicity test (OPPTS Test 

Guideline 870.3465); a bacterial reverse 

mutation test (OPPTS Test Guideline 

870.5100); a ready biodegradability test 

(OECD Test Guideline 301D) closed 

bottle method; a fish early-life stage 

toxicity test (OPPTS Test Guideline 

850.1400); a daphnid chronic toxicity 

test (OPPTS Test Guideline 850.1300); 

and an algal toxicity test (OCSPP Test 

Guideline 850.4500) would help 

characterize the human health and 

environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10847. 

mstockstill on DSK4VPTVN1PROD with RULES

32010 Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 

PMN Number P–14–875 

Chemical name: Aryloxyalkyl amine 

(generic). 

CAS number: Claimed confidential. 

Basis for action: The PMN states that 

the substance will be used as an 

intermediate. Based on test data on the 

PMN substance and SAR analysis of test 

data on analogous aliphatic amines, 

EPA predicts toxicity to aquatic 

organisms may occur at concentrations 

that exceed 44 ppb of the PMN 

substance in surface waters. As 

described in the PMN, releases of the 

substance are not expected to result in 

surface water concentrations that exceed 

44 ppb. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

any use resulting in surface water 

concentrations exceeding 44 ppb may 

cause significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(i) and 

(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a ready 

biodegradability test (OECD Test 

Guideline 301) and an algal toxicity test 

(OCSPP Test Guideline 850.4500) would 

help characterize the environmental 

effects of the PMN substance. 

CFR citation: 40 CFR 721.10848. 

PMN Numbers P–15–115 and P–15–116 

Chemical names: (P–15–115) Phenolbiphenyl-formaldehyde polycondensate 

(generic); (P–15–116) Polymer of 

phenol, biphenyl and resorcinol 

(generic). 

CAS numbers: Claimed confidential. 

Basis for action: The PMNs state that 

the generic (non-confidential) use of the 

substances will be in electric molding. 

Based on test data on the PMN 

substances as well as SAR analysis of 

test data on analogous phenols, EPA 

predicts toxicity to aquatic organisms 

may occur at concentrations that exceed 

5 ppb of the PMN substances in surface 

waters. As described in the PMNs, 

releases of the substances are not 

expected to result in surface water 

concentrations that exceed 5 ppb. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substances may 

present an unreasonable risk. EPA has 

determined, however, that any use 

resulting in surface water 

concentrations exceeding 5 ppb may 

cause significant adverse environmental 

effects. Based on this information, the 

PMN substances meet the concern 

criteria at § 721.170(b)(4)(i) and 

(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a water 

solubility test (OECD Test Guideline 

105); a fish early-life stage toxicity test 

(OPPTS Test Guideline 850.1400); and a 

daphnid chronic toxicity test (OPPTS 

Test Guideline 850.1300) would help 

characterize the environmental effects of 

the PMN substances. Testing may be 

conducted on either P–15–115 or P–15– 

116 and results should include a GPC 

analysis of molecular weight 

distribution. 

CFR citations: 40 CFR 721.10849 (P– 

15–115) and 40 CFR 721.10850 (P–15– 

116) 

V. Rationale and Objectives of the Rule 

A. Rationale 

During review of the PMNs submitted 

for the chemical substances that are 

subject to these SNURs, EPA concluded 

that for 2 of the 22 chemical substances, 

regulation was warranted under TSCA 

section 5(e), pending the development 

of information sufficient to make 

reasoned evaluations of the health or 

environmental effects of the chemical 

substances. The basis for such findings 

is outlined in Unit IV. Based on these 

findings, TSCA section 5(e) consent 

orders requiring the use of appropriate 

exposure controls were negotiated with 

the PMN submitters. The SNUR 

provisions for these chemical 

substances are consistent with the 

provisions of the TSCA section 5(e) 

consent orders. These SNURs are 

promulgated pursuant to § 721.160 (see 

Unit VI.). 

In the other 20 cases, where the uses 

are not regulated under a TSCA section 

5(e) consent order, EPA determined that 

one or more of the criteria of concern 

established at § 721.170 were met, as 

discussed in Unit IV. 

B. Objectives 

EPA is issuing these SNURs for 

specific chemical substances which 

have undergone premanufacture review 

because the Agency wants to achieve 

the following objectives with regard to 

the significant new uses designated in 

this rule: 

• EPA will receive notice of any 

person’s intent to manufacture or 

process a listed chemical substance for 

the described significant new use before 

that activity begins. 

• EPA will have an opportunity to 

review and evaluate data submitted in a 

SNUN before the notice submitter 

begins manufacturing or processing a 

listed chemical substance for the 

described significant new use. 

• EPA will be able to regulate 

prospective manufacturers or processors 

of a listed chemical substance before the 

described significant new use of that 

chemical substance occurs, provided 

that regulation is warranted pursuant to 

TSCA sections 5(e), 5(f), 6, or 7. 

• EPA will ensure that all 

manufacturers and processors of the 

same chemical substance that is subject 

to a TSCA section 5(e) consent order are 

subject to similar requirements. 

Issuance of a SNUR for a chemical 

substance does not signify that the 

chemical substance is listed on the 

TSCA Chemical Substance Inventory 

(TSCA Inventory). Guidance on how to 

determine if a chemical substance is on 

the TSCA Inventory is available on the 

Internet at http://www.epa.gov/opptintr/ 

existingchemicals/pubs/tscainventory/

index.html. 

VI. Direct Final Procedures 

EPA is issuing these SNURs as a 

direct final rule, as described in 

§ 721.160(c)(3) and § 721.170(d)(4). In 

accordance with § 721.160(c)(3)(ii) and 

§ 721.170(d)(4)(i)(B), the effective date 

of this rule is August 4, 2015 without 

further notice, unless EPA receives 

written adverse or critical comments, or 

notice of intent to submit adverse or 

critical comments before July 6, 2015. 

If EPA receives written adverse or 

critical comments, or notice of intent to 

submit adverse or critical comments, on 

one or more of these SNURs before July 

6, 2015, EPA will withdraw the relevant 

sections of this direct final rule before 

its effective date. EPA will then issue a 

proposed SNUR for the chemical 

substance(s) on which adverse or 

critical comments were received, 

providing a 30-day period for public 

comment. 

This rule establishes SNURs for a 

number of chemical substances. Any 

person who submits adverse or critical 

comments, or notice of intent to submit 

adverse or critical comments, must 

identify the chemical substance and the 

new use to which it applies. EPA will 

not withdraw a SNUR for a chemical 

substance not identified in the 

comment. 

VII. Applicability of the Significant 

New Use Designation 

To establish a significant new use, 

EPA must determine that the use is not 

ongoing. The chemical substances 

subject to this rule have undergone 

premanufacture review. In cases where 

EPA has not received a notice of 

commencement (NOC) and the chemical 

substance has not been added to the 

TSCA Inventory, no person may 

commence such activities without first 

submitting a PMN. Therefore, for 

chemical substances for which an NOC 

mstockstill on DSK4VPTVN1PROD with RULES

Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 32011 

has not been submitted EPA concludes 

that the designated significant new uses 

are not ongoing. 

When chemical substances identified 

in this rule are added to the TSCA 

Inventory, EPA recognizes that, before 

the rule is effective, other persons might 

engage in a use that has been identified 

as a significant new use. However, 

TSCA section 5(e) consent orders have 

been issued for 2 of the 22 chemical 

substances, and the PMN submitters are 

prohibited by the TSCA section 5(e) 

consent orders from undertaking 

activities which would be designated as 

significant new uses. The identities of 

16 of the 22 chemical substances subject 

to this rule have been claimed as 

confidential and EPA has received no 

post-PMN bona fide submissions (per 

§§ 720.25 and 721.11). Based on this, 

the Agency believes that it is highly 

unlikely that any of the significant new 

uses described in the regulatory text of 

this rule are ongoing. 

Therefore, EPA designates June 5, 

2015 as the cutoff date for determining 

whether the new use is ongoing. Persons 

who begin commercial manufacture or 

processing of the chemical substances 

for a significant new use identified as of 

that date would have to cease any such 

activity upon the effective date of the 

final rule. To resume their activities, 

these persons would have to first 

comply with all applicable SNUR 

notification requirements and wait until 

the notice review period, including any 

extensions, expires. If such a person met 

the conditions of advance compliance 

under § 721.45(h), the person would be 

considered exempt from the 

requirements of the SNUR. Consult the 

Federal Register document of April 24, 

1990 for a more detailed discussion of 

the cutoff date for ongoing uses. 

VIII. Test Data and Other Information 

EPA recognizes that TSCA section 5 

does not require developing any 

particular test data before submission of 

a SNUN. The two exceptions are: 

1. Development of test data is 

required where the chemical substance 

subject to the SNUR is also subject to a 

test rule under TSCA section 4 (see 

TSCA section 5(b)(1)). 

2. Development of test data may be 

necessary where the chemical substance 

has been listed under TSCA section 

5(b)(4) (see TSCA section 5(b)(2)). 

In the absence of a TSCA section 4 

test rule or a TSCA section 5(b)(4) 

listing covering the chemical substance, 

persons are required only to submit test 

data in their possession or control and 

to describe any other data known to or 

reasonably ascertainable by them (see 40 

CFR 720.50). However, upon review of 

PMNs and SNUNs, the Agency has the 

authority to require appropriate testing. 

In cases where EPA issued a TSCA 

section 5(e) consent order that requires 

or recommends certain testing, Unit IV. 

lists those tests. Unit IV. also lists 

recommended testing for non-5(e) 

SNURs. Descriptions of tests are 

provided for informational purposes. 

EPA strongly encourages persons, before 

performing any testing, to consult with 

the Agency pertaining to protocol 

selection. To access the OCSPP test 

guidelines referenced in this document 

electronically, please go to http://

www.epa.gov/ocspp and select ‘‘Test 

Methods and Guidelines.’’ The 

Organisation for Economic Co-operation 

and Development (OECD) test 

guidelines are available from the OECD 

Bookshop at http://

www.oecdbookshop.org or SourceOECD 

at http://www.sourceoecd.org. 

In the TSCA section 5(e) consent 

orders for several of the chemical 

substances regulated under this rule, 

EPA has established production volume 

limits in view of the lack of data on the 

potential health and environmental 

risks that may be posed by the 

significant new uses or increased 

exposure to the chemical substances. 

These limits cannot be exceeded unless 

the PMN submitter first submits the 

results of toxicity tests that would 

permit a reasoned evaluation of the 

potential risks posed by these chemical 

substances. Under recent TSCA section 

5(e) consent orders, each PMN submitter 

is required to submit each study before 

reaching the specified production limit. 

Listings of the tests specified in the 

TSCA section 5(e) consent orders are 

included in Unit IV. The SNURs contain 

the same production volume limits as 

the TSCA section 5(e) consent orders. 

Exceeding these production limits is 

defined as a significant new use. 

Persons who intend to exceed the 

production limit must notify the Agency 

by submitting a SNUN at least 90 days 

in advance of commencement of nonexempt commercial manufacture, or 

processing. 

The recommended tests specified in 

Unit IV. may not be the only means of 

addressing the potential risks of the 

chemical substance. However, 

submitting a SNUN without any test 

data may increase the likelihood that 

EPA will take action under TSCA 

section 5(e), particularly if satisfactory 

test results have not been obtained from 

a prior PMN or SNUN submitter. EPA 

recommends that potential SNUN 

submitters contact EPA early enough so 

that they will be able to conduct the 

appropriate tests. 

SNUN submitters should be aware 

that EPA will be better able to evaluate 

SNUNs which provide detailed 

information on the following: 

• Human exposure and 

environmental release that may result 

from the significant new use of the 

chemical substances. 

• Potential benefits of the chemical 

substances. 

• Information on risks posed by the 

chemical substances compared to risks 

posed by potential substitutes. 

IX. Procedural Determinations 

By this rule, EPA is establishing 

certain significant new uses which have 

been claimed as CBI subject to Agency 

confidentiality regulations at 40 CFR 

part 2 and 40 CFR part 720, subpart E. 

Absent a final determination or other 

disposition of the confidentiality claim 

under 40 CFR part 2 procedures, EPA is 

required to keep this information 

confidential. EPA promulgated a 

procedure to deal with the situation 

where a specific significant new use is 

CBI, at 40 CFR 721.1725(b)(1). 

Under these procedures a 

manufacturer or processor may request 

EPA to determine whether a proposed 

use would be a significant new use 

under the rule. The manufacturer or 

processor must show that it has a bona 

fide intent to manufacture or process the 

chemical substance and must identify 

the specific use for which it intends to 

manufacture or process the chemical 

substance. If EPA concludes that the 

person has shown a bona fide intent to 

manufacture or process the chemical 

substance, EPA will tell the person 

whether the use identified in the bona 

fide submission would be a significant 

new use under the rule. Since most of 

the chemical identities of the chemical 

substances subject to these SNURs are 

also CBI, manufacturers and processors 

can combine the bona fide submission 

under the procedure in § 721.1725(b)(1) 

with that under § 721.11 into a single 

step. 

If EPA determines that the use 

identified in the bona fide submission 

would not be a significant new use, i.e., 

the use does not meet the criteria 

specified in the rule for a significant 

new use, that person can manufacture or 

process the chemical substance so long 

as the significant new use trigger is not 

met. In the case of a production volume 

trigger, this means that the aggregate 

annual production volume does not 

exceed that identified in the bona fide 

submission to EPA. Because of 

confidentiality concerns, EPA does not 

typically disclose the actual production 

volume that constitutes the use trigger. 

Thus, if the person later intends to 

mstockstill on DSK4VPTVN1PROD with RULES

32012 Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 

exceed that volume, a new bona fide 

submission would be necessary to 

determine whether that higher volume 

would be a significant new use. 

X. SNUN Submissions 

According to § 721.1(c), persons 

submitting a SNUN must comply with 

the same notification requirements and 

EPA regulatory procedures as persons 

submitting a PMN, including 

submission of test data on health and 

environmental effects as described in 40 

CFR 720.50. SNUNs must be submitted 

on EPA Form No. 7710–25, generated 

using e-PMN software, and submitted to 

the Agency in accordance with the 

procedures set forth in 40 CFR 720.40 

and § 721.25. E–PMN software is 

available electronically at http://

www.epa.gov/opptintr/newchems. 

XI. Economic Analysis 

EPA has evaluated the potential costs 

of establishing SNUN requirements for 

potential manufacturers and processors 

of the chemical substances subject to 

this rule. EPA’s complete economic 

analysis is available in the docket under 

docket ID number EPA–HQ–OPPT– 

2015–0220. 

XII. Statutory and Executive Order 

Reviews 

A. Executive Order 12866 

This action establishes SNURs for 

several new chemical substances that 

were the subject of PMNs, or TSCA 

section 5(e) consent orders. The Office 

of Management and Budget (OMB) has 

exempted these types of actions from 

review under Executive Order 12866, 

entitled ‘‘Regulatory Planning and 

Review’’ (58 FR 51735, October 4, 1993). 

B. Paperwork Reduction Act (PRA) 

According to PRA (44 U.S.C. 3501 et 

seq.), an agency may not conduct or 

sponsor, and a person is not required to 

respond to a collection of information 

that requires OMB approval under PRA, 

unless it has been approved by OMB 

and displays a currently valid OMB 

control number. The OMB control 

numbers for EPA’s regulations in title 40 

of the CFR, after appearing in the 

Federal Register, are listed in 40 CFR 

part 9, and included on the related 

collection instrument or form, if 

applicable. EPA is amending the table in 

40 CFR part 9 to list the OMB approval 

number for the information collection 

requirements contained in this action. 

This listing of the OMB control numbers 

and their subsequent codification in the 

CFR satisfies the display requirements 

of PRA and OMB’s implementing 

regulations at 5 CFR part 1320. This 

Information Collection Request (ICR) 

was previously subject to public notice 

and comment prior to OMB approval, 

and given the technical nature of the 

table, EPA finds that further notice and 

comment to amend it is unnecessary. As 

a result, EPA finds that there is ‘‘good 

cause’’ under section 553(b)(3)(B) of the 

Administrative Procedure Act (5 U.S.C. 

553(b)(3)(B)) to amend this table 

without further notice and comment. 

The information collection 

requirements related to this action have 

already been approved by OMB 

pursuant to PRA under OMB control 

number 2070–0012 (EPA ICR No. 574). 

This action does not impose any burden 

requiring additional OMB approval. If 

an entity were to submit a SNUN to the 

Agency, the annual burden is estimated 

to average between 30 and 170 hours 

per response. This burden estimate 

includes the time needed to review 

instructions, search existing data 

sources, gather and maintain the data 

needed, and complete, review, and 

submit the required SNUN. 

Send any comments about the 

accuracy of the burden estimate, and 

any suggested methods for minimizing 

respondent burden, including through 

the use of automated collection 

techniques, to the Director, Collection 

Strategies Division, Office of 

Environmental Information (2822T), 

Environmental Protection Agency, 1200 

Pennsylvania Ave. NW., Washington, 

DC 20460–0001. Please remember to 

include the OMB control number in any 

correspondence, but do not submit any 

completed forms to this address. 

C. Regulatory Flexibility Act (RFA) 

On February 18, 2012, EPA certified 

pursuant to RFA section 605(b) (5 U.S.C. 

601 et seq.), that promulgation of a 

SNUR does not have a significant 

economic impact on a substantial 

number of small entities where the 

following are true: 

1. A significant number of SNUNs 

would not be submitted by small 

entities in response to the SNUR. 

2. The SNUR submitted by any small 

entity would not cost significantly more 

than $8,300. 

A copy of that certification is 

available in the docket for this action. 

This action is within the scope of the 

February 18, 2012 certification. Based 

on the Economic Analysis discussed in 

Unit XI. and EPA’s experience 

promulgating SNURs (discussed in the 

certification), EPA believes that the 

following are true: 

• A significant number of SNUNs 

would not be submitted by small 

entities in response to the SNUR. 

• Submission of the SNUN would not 

cost any small entity significantly more 

than $8,300. 

Therefore, the promulgation of the 

SNUR would not have a significant 

economic impact on a substantial 

number of small entities. 

D. Unfunded Mandates Reform Act 

(UMRA) 

Based on EPA’s experience with 

proposing and finalizing SNURs, State, 

local, and Tribal governments have not 

been impacted by these rulemakings, 

and EPA does not have any reasons to 

believe that any State, local, or Tribal 

government will be impacted by this 

action. As such, EPA has determined 

that this action does not impose any 

enforceable duty, contain any unfunded 

mandate, or otherwise have any effect 

on small governments subject to the 

requirements of UMRA sections 202, 

203, 204, or 205 (2 U.S.C. 1501 et seq.). 

E. Executive Order 13132 

This action will not have a substantial 

direct effect on States, on the 

relationship between the national 

government and the States, or on the 

distribution of power and 

responsibilities among the various 

levels of government, as specified in 

Executive Order 13132, entitled 

‘‘Federalism’’ (64 FR 43255, August 10, 

1999). 

F. Executive Order 13175 

This action does not have Tribal 

implications because it is not expected 

to have substantial direct effects on 

Indian Tribes. This action does not 

significantly nor uniquely affect the 

communities of Indian Tribal 

governments, nor does it involve or 

impose any requirements that affect 

Indian Tribes. Accordingly, the 

requirements of Executive Order 13175, 

entitled ‘‘Consultation and Coordination 

with Indian Tribal Governments’’ (65 FR 

67249, November 9, 2000), do not apply 

to this action. 

G. Executive Order 13045 

This action is not subject to Executive 

Order 13045, entitled ‘‘Protection of 

Children from Environmental Health 

Risks and Safety Risks’’ (62 FR 19885, 

April 23, 1997), because this is not an 

economically significant regulatory 

action as defined by Executive Order 

12866, and this action does not address 

environmental health or safety risks 

disproportionately affecting children. 

H. Executive Order 13211 

This action is not subject to Executive 

Order 13211, entitled ‘‘Actions 

Concerning Regulations That 

mstockstill on DSK4VPTVN1PROD with RULES

Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 32013 

Significantly Affect Energy Supply, 

Distribution, or Use’’ (66 FR 28355, May 

22, 2001), because this action is not 

expected to affect energy supply, 

distribution, or use and because this 

action is not a significant regulatory 

action under Executive Order 12866. 

I. National Technology Transfer and 

Advancement Act (NTTAA) 

In addition, since this action does not 

involve any technical standards, 

NTTAA section 12(d) (15 U.S.C. 272 

note), does not apply to this action. 

J. Executive Order 12898 

This action does not entail special 

considerations of environmental justice 

related issues as delineated by 

Executive Order 12898, entitled 

‘‘Federal Actions to Address 

Environmental Justice in Minority 

Populations and Low-Income 

Populations’’ (59 FR 7629, February 16, 

1994). 

XIII. Congressional Review Act 

Pursuant to the Congressional Review 

Act (5 U.S.C. 801 et seq.), EPA will 

submit a report containing this rule and 

other required information to the U.S. 

Senate, the U.S. House of 

Representatives, and the Comptroller 

General of the United States prior to 

publication of the rule in the Federal 

Register. This action is not a ‘‘major 

rule’’ as defined by 5 U.S.C. 804(2). 

List of Subjects 

40 CFR Part 9 

Environmental protection, Reporting 

and recordkeeping requirements. 

40 CFR Part 721 

Environmental protection, Chemicals, 

Hazardous substances, Reporting and 

recordkeeping requirements. 

Dated: May 28, 2015. 

Maria J. Doa, 

Director, Chemical Control Division, Office 

of Pollution Prevention and Toxics. 

Therefore, 40 CFR parts 9 and 721 are 

amended as follows: 

PART 9—[AMENDED] 

■ 1. The authority citation for part 9 

continues to read as follows: 

Authority: 7 U.S.C. 135 et seq., 136–136y; 

15 U.S.C. 2001, 2003, 2005, 2006, 2601–2671; 

21 U.S.C. 331j, 346a, 348; 31 U.S.C. 9701; 33 

U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318, 

1321, 1326, 1330, 1342, 1344, 1345(d) and 

(e), 1361; E.O. 11735, 38 FR 21243, 3 CFR, 

1971–1975 Comp. p. 973; 42 U.S.C. 241, 

242b, 243, 246, 300f, 300g, 300g–1, 300g–2, 

300g–3, 300g–4, 300g–5, 300g–6, 300j–1, 

300j–2, 300j–3, 300j–4, 300j–9, 1857 et seq., 

6901–6992k, 7401–7671q, 7542, 9601–9657, 

11023, 11048. 

■ 2. In § 9.1, add the following sections 

in numerical order under the 

undesignated center heading 

‘‘Significant New Uses of Chemical 

Substances’’ to read as follows: 

§ 9.1 OMB approvals under the Paperwork 

Reduction Act. 

* * * * * 

40 CFR citation OMB control 

No. 

* * * * * 

Significant New Uses of Chemical 

Substances 

* * * * * 

721.10830 ................................. 2070–0012 

721.10831 ................................. 2070–0012 

721.10832 ................................. 2070–0012 

721.10833 ................................. 2070–0012 

721.10834 ................................. 2070–0012 

721.10835 ................................. 2070–0012 

721.10836 ................................. 2070–0012 

721.10837 ................................. 2070–0012 

721.10838 ................................. 2070–0012 

721.10839 ................................. 2070–0012 

721.10840 ................................. 2070–0012 

721.10841 ................................. 2070–0012 

721.10842 ................................. 2070–0012 

721.10843 ................................. 2070–0012 

721.10844 ................................. 2070–0012 

721.10845 ................................. 2070–0012 

721.10846 ................................. 2070–0012 

721.10847 ................................. 2070–0012 

721.10848 ................................. 2070–0012 

721.10849 ................................. 2070–0012 

721.10850 ................................. 2070–0012 

* * * * * 

* * * * * 

PART 721—[AMENDED] 

■ 3. The authority citation for part 721 

continues to read as follows: 

Authority: 15 U.S.C. 2604, 2607, and 

2625(c). 

■ 4. Add § 721.10830 to subpart E to 

read as follows: 

§ 721.18030 2-Butene, 1,1,1,4,4,4- 

hexafluoro-, (2Z)-. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

2-butene, 1,1,1,4,4,4-hexafluoro-, (2Z)- 

(PMN P–11–549; CAS No. 692–49–9) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(f), (j), and (o). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 5. Add § 721.10831 to subpart E to 

read as follows: 

§ 721.18031 Aluminum phosphate 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as aluminum phosphate 

(PMN P–13–690) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. The requirements of this 

section do not apply to quantities of the 

PMN substance that has been 

completely reacted (cured) or entrained 

into a polymer matrix. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(4) and (a)(6)(1). When 

determining which persons are 

reasonably likely to be exposed as 

required for § 721.63(a)(4), engineering 

control measures (e.g., enclosure or 

confinement of the operation, general 

and local ventilation) or administrative 

control measures (e.g., workplace 

policies and procedures) shall be 

considered and implemented to prevent 

exposure, where feasible. A National 

Institute for Occupational Safety and 

Health (NIOSH)-certified respirator with 

an Assigned Protection Factor (APF) of 

at least 10 meet the requirements of 

§ 721.63(a)(4). 

(ii) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=87). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (e), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

mstockstill on DSK4VPTVN1PROD with RULES

32014 Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 

■ 6. Add § 721.10832 to subpart E to 

read as follows: 

§ 721.10832 Alkyl triazine (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as alkyl triazine (PMN P–13– 

872) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=130). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 7. Add § 721.10833 to subpart E to 

read as follows: 

§ 721.10833 Substituted bis 2,6-xylenol 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as substituted bis 2,6- 

xylenol (PMN P–13–930) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. The 

requirements of this section do not 

apply to quantities of the PMN 

substance that have been incorporated 

into an article or has been incorporated 

into a polymer matrix. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (a)(2)(i), (a)(3), (a)(4), 

(a)(6)(i), (a)(6)(ii), (b)(concentration set 

at 1.0 percent), and (c). When 

determining which persons are 

reasonably likely to be exposed as 

required for § 721.63(a)(4), engineering 

control measures (e.g., enclosure or 

confinement of the operation, general 

and local ventilation) or administrative 

control measures (e.g., workplace 

policies and procedures) shall be 

considered and implemented to prevent 

exposure, where feasible. The following 

National Institute for Occupational 

Safety and Health (NIOSH)-certified 

respirators with an assigned protection 

factor (APF) of at least 50 meet the 

requirements of § 721.63(a)(4): 

(A) NIOSH-certified power airpurifying respirator with a hood or 

helmet and with appropriate gas/vapor 

(acid gas, organic vapor, or substance 

specific) cartridges in combination with 

HEPA filters. 

(B) NIOSH-certified continuous flow 

supplied-air respirator equipped with a 

loose fitting facepiece, hood, or helmet. 

(C) NIOSH-certified negative pressure 

(demand) supplied-air respirator with a 

full facepiece. 

(ii) Hazard communication. 

Requirements as specified in 

§ 721.72(a), (b), (c), (d), (e), 

(f)(concentration set at 1.0 percent), 

(g)(1)(The PMN substance may cause 

sensitization, eye irritation, internal 

organ effects, and developmental 

effects), (g)(2), (g)(3), (g)(4)(i), and (g)(5). 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(g) and (q). 

(iv) Release to water. (A) 

Requirements as specified in 

§ 721.90(a)(4), (b)(4), and (c)(4) N=6. 

However the requirements of 

§ 721.91(a)(4) do not apply. Instead, if 

control technologies are in place to treat 

the waste stream containing the PMN 

substance, the amount of the PMN 

substance reasonably likely to be 

removed from the waste stream by such 

treatment may be subtracted in 

calculating the number of kilograms 

releases. No more than 40 percent 

removal efficiency may be attributed to 

such treatment. 

(B) In lieu of calculating the quotient, 

monitoring or alternative calculations 

may be used to predict the surface water 

concentrations expected to result from 

the intended release of the substance, if 

the monitoring procedures or 

calculations have been approved for 

such purposes by EPA. 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (i), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(iii) of this section. 

■ 8. Add § 721.10834 to subpart E to 

read as follows: 

§ 721.10834 Heteropolycyclic diacrylate 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as heteropolycyclic 

diacrylate (PMN P–14–20) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (a)(2)(i), (a)(2)(iii), (a)(3), 

(a)(4), (a)(6)(i), (a)(6)(ii), (b) 

(concentration set at 1.0 percent), and 

(c). When determining which persons 

are reasonably likely to be exposed as 

required for § 721.63(a)(4), engineering 

control measures (e.g., enclosure or 

confinement of the operation, general 

and local ventilation) or administrative 

control measures (e.g., workplace 

policies and procedures) shall be 

considered and implemented to prevent 

exposure, where feasible. The following 

National Institute for Occupational 

Safety and Health (NIOSH)-certified 

respirators with an assigned protection 

factor (APF) of at least 10 meet the 

requirements of § 721.63(a)(4): 

(A) NIOSH-certified power airpurifying respirator with a hood or 

helmet and with appropriate gas/vapor 

(acid gas, organic vapor, or substance 

specific) cartridges in combination with 

HEPA filters. 

(B) NIOSH-certified continuous flow 

supplied-air respirator equipped with a 

loose fitting facepiece, hood, or helmet. 

(ii) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=120). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (e), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 9. Add § 721.10835 to subpart E to 

read as follows: 

§ 721.10835 1,6-Hexanediamine, N1-(6- 

aminohexyl)-, polymer with 2- 

(chloromethyl)oxirane, N-(dithiocarboxy) 

derivs., sodium salts. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

1,6-Hexanediamine, N1-(6-aminohexyl)- 

, polymer with 2-(chloromethyl)oxirane, 

N-(dithiocarboxy) derivs., sodium salts 

mstockstill on DSK4VPTVN1PROD with RULES

Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 32015 

(PMN P–14–66; CAS No. 1459738–70–5) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 10. Add § 721.10836 to subpart E to 

read as follows: 

§ 721.10836 Dimethylaminoalkyl alkene 

amide (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as dimethylaminoalkyl 

alkene amide (PMN P–14–209) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(i) of this section. 

■ 11. Add § 721.10837 to subpart E to 

read as follows: 

§ 721.10837 Substituted naphthalene 

polymer glycidyl ether (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as substituted naphthalene 

polymer glycidyl ether (PMN P–14–452) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 12. Add § 721.10838 to subpart E to 

read as follows: 

§ 721.10838 Alkylpolycarboxylic acid, 

derivative, tris(fluorinatedalkoxy)alkyl ester 

salt (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as alkylpolycarboxylic acid, 

derivative, tris(fluorinatedalkoxy)alkyl 

ester salt (PMN P–14–473) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=6). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 13. Add § 721.10839 to subpart E to 

read as follows: 

§ 721.10839 Tricyclo[3.3.1.13,7]decan-1- 

amine, N,N-dimethyl-. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

tricyclo[3.3.1.13,7]decan-1-amine, N,Ndimethyl- (PMN P–14–476; CAS No. 

3717–40–6) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=8). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c) and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 14. Add § 721.10840 to subpart E to 

read as follows: 

§ 721.10840 Sulfosuccinic acid ester, 

alkylamine derivs., sodium salt (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as sulfosuccinic acid ester, 

alkylamine derivs., sodium salt (PMN 

P–14–510) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=94). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 15. Add § 721.10841 to subpart E to 

read as follows: 

§ 721.10841 Bismuth nitrate oxide 

(Bi3(NO3)O4). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

bismuth nitrate oxide (Bi3(NO3)O4) 

(PMN P–14–603; CAS No. 1417164–49– 

8) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(4), (a)(6)(i), and (c). When 

determining which persons are 

reasonably likely to be exposed as 

required for § 721.63(a)(4), engineering 

control measures (e.g., enclosure or 

confinement of the operation, general 

mstockstill on DSK4VPTVN1PROD with RULES

32016 Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 

and local ventilation) or administrative 

control measures (e.g., workplace 

policies and procedures) shall be 

considered and implemented to prevent 

exposure, where feasible. The following 

National Institute for Occupational 

Safety and Health (NIOSH)-certified 

respirator with an assigned protection 

factor (APF) of at least 10 meets the 

minimum requirements for 

§ 721.63(a)(4): NIOSH-certified airpurifying elastomeric half-mask 

respirator equipped with N100 (if oil 

aerosols absent), R100, or P100 filters. 

(ii) Industrial commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (d), and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(i) of this section. 

■ 16. Add § 721.10842 to subpart E to 

read as follows: 

§ 721.10842 Substituted cyclosiloxane 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as substituted cyclosiloxane 

(PMN P–14–605) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Industrial commercial, and 

consumer activities. A significant new 

use is any use other than as a refractive 

index modifier component for lightemitting diode (LED) chips. 

(ii) Release to water. Requirements as 

specified in § 721.90(a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), (i), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 17. Add § 721.10843 to subpart E to 

read as follows: 

§ 721.10843 Substituted amide aromatic 

carboxylic acid, metal salt (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substances identified 

generically as substituted amide 

aromatic carboxylic acid, metal salt 

(PMNs P–14–666 and P–14–668) are 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (i) are 

applicable to manufacturers and 

processors of these substances. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(i) of this section. 

■ 18. Add § 721.10844 to subpart E to 

read as follows: 

§ 721.10844 Graphene nanoplatelets 

having a predominant thickness of 1–10 

layers with lateral dimension predominantly 

less than 2 microns. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

graphene nanoplatelets having a 

predominant thickness of 1–10 layers 

with lateral dimension predominantly 

less than 2 microns (PMN P–14–763) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. The 

requirements of this section do not 

apply to quantities of the PMN 

substance that have been embedded or 

incorporated into a polymer matrix that 

itself has been reacted (cured); 

embedded in a permanent solid polymer 

form that is not intended to undergo 

further processing, except mechanical 

processing; or imported into an article 

as defined at 40 CFR 720.3(c). 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in 

§ 721.63(a)(1), (a)(2)(i), (a)(2)(ii), (a)(3), 

(a)(4), (a)(6)(i), (a)(6)(ii), (b) 

(concentration set at 1.0 percent), and 

(c). When determining which persons 

are reasonably likely to be exposed as 

required for § 721.63(a)(4), engineering 

control measures (e.g., enclosure or 

confinement of the operation, general 

and local ventilation) or administrative 

control measures (e.g., workplace 

policies and procedures) shall be 

considered and implemented to prevent 

exposure, where feasible. The following 

National Institute for Occupational 

Safety and Health (NIOSH)-certified 

respirators meet the requirements of 

§ 721.63(a)(4): 

(A) NIOSH-certified power airpurifying, tight-fitting full-face 

respirator equipped with an N–100, P– 

100, or R–100 cartridge. 

(B) NIOSH-certified power airpurifying particulate respirator with an 

assigned protection factor (APF) of at 

least 50. 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(k), (q), and (y)(1). 

(iii) Release to water. Requirements as 

specified in § 721.90(a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (e), (i), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(ii) of this section. 

■ 19. Add § 721.10845 to subpart E to 

read as follows: 

§ 721.10845 Methanaminium, N-[4-[[4- 

(dimethylamino)phenyl]phenylmethylene]- 

2,5-cyclohexadien-1-ylidene]-N-methyl-, 

ethanedioate, ethanedioate (2:2:1). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

methanaminium, N-[4-[[4- 

(dimethylamino)phenyl

]phenylmethylene]-2,5-cyclohexadien-1- 

ylidene]-N-methyl-, ethanedioate, 

ethanedioate (2:2:1) (PMN P–14–781; 

CAS No. 2437–29–8) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial commercial, and 

consumer activities. Requirements as 

specified in § 721.80(f). 

mstockstill on DSK4VPTVN1PROD with RULES

Federal Register / Vol. 80, No. 108 / Friday, June 5, 2015 / Rules and Regulations 32017 

(ii) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), (i), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 20. Add § 721.10846 to subpart E to 

read as follows: 

§ 721.10846 Sulfurized hydrocarbon 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as sulfurized hydrocarbon 

(PMN P–14–811) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Industrial commercial, and 

consumer activities. Requirements as 

specified in § 721.80. A significant new 

use is any use where less than 80 

percent of the low molecular weight 

species are greater than 1,000 daltons. 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (i) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to paragraph 

(a)(2)(i) of this section. 

■ 21. Add § 721.10847 to subpart E to 

read as follows: 

§ 721.10847 Oxiranemethanaminium, 

N,N,N-trimethyl-, bromide. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

oxiranemethanaminium, N,N,Ntrimethyl-, bromide (PMN P–14–821; 

CAS No. 13895–77–7) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial commercial, and 

consumer activities. Requirements as 

specified in § 721.80(v)(1), (w)(1), and 

(x)(1). 

(ii) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=28). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), (i), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 22. Add § 721.10848 to subpart E to 

read as follows: 

§ 721.10848 Aryloxyalkyl amine (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as aryloxyalkyl amine (PMN 

P–14–875) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=44). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 23. Add § 721.10849 to subpart E to 

read as follows: 

§ 721.10849 Phenol-biphenylformaldehyde polycondensate (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as phenol-biphenylformaldehyde polycondensate (PMN P– 

15–115) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=5). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 24. Add § 721.10850 to subpart E to 

read as follows: 

§ 721.10850 Polymer of phenol, biphenyl 

and resorcinol (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as polymer of phenol, 

biphenyl and resorcinol (PMN P–15– 

116) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90(a)(4), (b)(4), and 

(c)(4) (N=5). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in 

§ 721.125(a) through (c), and (k) are 

applicable to manufacturers and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

[FR Doc. 2015–13670 Filed 6–4–15; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

40 CFR Part 52 

[EPA–R07–OAR–2014–0528; FRL–9928–59– 

Region 7] 

Approval and Promulgation of 

Implementation Plans; State of 

Kansas; Infrastructure SIP 

Requirements for the 2010 Sulfur 

Dioxide National Ambient Air Quality 

Standard 

AGENCY: Environmental Protection 

Agency. 

ACTION: Final rule. 

SUMMARY: The Environmental Protection 

Agency (EPA) is taking final action to 

mstockstill on DSK4VPTVN1PROD with RULES